CClinicalTrials.gg
CompletedNCT01064258Updated Feb 16, 2010

Trial of Auto Continuous Positive Airway Pressure (CPAP)

A Phase 1 interventional study of CPAP and autoCPAP in Obstructive Sleep Apnea, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-02-16.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
1
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Background: In patients with obstructive sleep apnea, automatic continuous positive airway pressure machines (autoCPAP) are said to be capable of identifying various breathing abnormalities during sleep and to correct them by increasing progressively the positive pressure applied to the airway. Once breathing becomes normal, pressure slowly declines. AutoCPAP devices have never been tested in Phase I studies. The investigators hypothesised that normal breathing would not be recognised as such, and that pressure would increase even in a normal subject.

Read the detailed description

Material and Methods: We will submit one normal (confirmed with two polysomnographies, PSG) subject to a double blind study. Pairs of PSG will be performed on successive days once a week, one night with a 4 cm water fixed pressure CPAP device, previously shown not to disturb the subject's sleep and breathing, the other night with one of five well known autoCPAP devices programmed to work between 4 and 15 cm H2O pressure. The same mask and headgear will be used throughout the study. The subject and the physicians reading the tracings will ignore which device is being used on which night.

02

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • treatment
  • CPAP
  • sleep apnea
03

In context

Sleep Apnea Syndromes

2,162 studies on the registry are indexed under Sleep Apnea Syndromes; 290 are open to participants now.

This study's enrollment of 1 is below the median of 53 across 1,386 interventional studies indexed under Sleep Apnea Syndromes.

Browse Sleep Apnea Syndromes studies →

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • normal subject
  • male and female
  • age 18 to 65 years old

Exclusion criteria

Exclusion Criteria:

  • obstructive sleep apnea
  • unable to sleep with a CPAP device
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
1 participant (actual)

Study arms

  • Active comparator
    fixed CPAP

    subject will sleep with a fixed CPAP device at minimal pressure

    Device: CPAP

  • Experimental
    autoCPAP

    the subject will sleep connected to an autoCPAP device

    Device: autoCPAP

Interventions

  • DeviceCPAP

    CPAP at 4 cm H2O

  • DeviceautoCPAP

    autoCPAP working between 4 and 15 cm H2O

06

What researchers measure

Primary outcomes

  1. number of episodes of increases in applied positive pressure, duration of each episode, and maximal pressure attained

    Time frame: one night

Secondary outcomes

  1. reasons for pressure increase and consequences of the increase on sleep continuity

    Time frame: one night

07

Study locations

1 site
  • Cliniques universitaires Saint-Luc
    Brussels, 1200, Belgium
08

References and documents

Publications

  • Mwenge GB, Dury M, Delguste P, Rodenstein D. Response of automatic continuous positive airway pressure devices in a normal subject. Eur Respir J. 2011 Jun;37(6):1530-3. doi: 10.1183/09031936.00139510. No abstract available. PubMed 21632834 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01064258
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborators
Cliniques universitaires Saint-Luc
First posted
Feb 8, 2010
Start date
Aug 2009
Primary completion
Oct 2009
Completion
Oct 2009
Last update
Feb 16, 2010

Study contacts

Daniel Rodenstein, MD
principal investigator · Cliniques universitaires Saint-Luc

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion